ARCHIVES

Wallen Pleads Guilty To Lesser Charges, To Pay $20,000 to CALGB, FDA

This article is from The Cancer Letter archive.

Vol. 10 No. 33 | August 31, 1984

Download PDF Visit The Full Archive

Related Articles

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Recompetitions Of DCT Contracts Okayed

March 3, 1989

RFA Available

January 15, 1999

NCI exceeds employment ceilings, must cut personnel in FY 2004, NIH says. Further cuts expected in extramural grant support staff.

January 30, 2004

GAO Offers Two Suggestions For Plant Screening

April 4, 1980

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996